Multiplicity of benign breast lesions is a risk factor for progression to breast cancer

Clinical Cancer Research

Volumn 13, Issue 18, 2007, Pages 5474-5479

  Worsham, Maria J ^a   Raju, Usha ^a   Lu, Mei ^a   Kapke, Alissa ^a   Cheng, Jingfang ^a   Wolman, Sandra R ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; CANCER GROWTH; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSCOPY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR;

ADULT; BREAST DISEASES; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; HYPERPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 34848856188     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0928     Document Type: Article

References (29)

1. Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005;143:446-57.
2. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-65.
3. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267:941-4.
4. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 2004;96:616-20.
5. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003;27:836-41.
6. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37.
7. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297-301.
8. Worsham MJ, Abrams J, Raju U, et al. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 2007;13:115-21.
9. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
10. Carter RE, Lipsitz SR, Tilley BC. Quasi-likelihood estimation for relative risk regression models. Biostatistics 2005;6:39-44.
11. Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
12. Page DL, Dupont WD. Histopathologic risk factors for breast cancer in women with benign breast disease. Semin Surg Oncol 1988;4:213-7.
13. Page DL, Dupont WD. Proliferative breast disease: diagnosis and implications. Science 1991;253:915-6.
14. Page DL, Dupont WD. Benign breast disease: indicators of increased breast cancer risk. Cancer Detect Prev 1992;16:93-7.
15. Kennedy M, Masterson AV, Kerin M, Flanagan F. Pathology and clinical relevance of radial scars: a review. J Clin Pathol 2003;56:721-4.
16. Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 1989;20:723-5.
17. Tamimi RM, Byrne C, Baer HJ, et al. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study. Breast Cancer Res 2005;7:R555-62.
18. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992;135:619-31.
19. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128:467-77.
20. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-6.
21. You JK, Kim EK, Kwak JY, et al. Focal fibrosis of the breast diagnosed by a sonographically guided core biopsy of nonpalpable lesions: imaging findings and clinical relevance. J Ultrasound Med 2005;24:1377-84.
22. Rosen EL, Soo MS, Bentley RC. Focal fibrosis: a common breast lesion diagnosed at imaging-guided core biopsy. AJR Am J Roentgenol 1999;173:1657-62.
23. Revelon G, Sherman ME, Gatewood OM, Brem RF. Focal fibrosis of the breast: imaging characteristics and histopathologic correlation. Radiology 2000;216:255-9.
24. Sklair-Levy M, Samuels TH, Catzavelos C, Hamilton P, Shumak R. Stromal fibrosis of the breast. AJR Am J Roentgenol 2001;177:573-7.
25. Hermann G, Schwartz IS. Focal fibrous disease of the breast: mammographic detection of an unappreciated condition. AJR Am J Roentgenol 1983;140:1245-6.
26. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993;15:196-208.
27. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997;19:310-27.
28. Wu C, Ray RM, Lin MG, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol 2004;160:945-60.
29. Yeh IT, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 2003;127:49-54.